|
1
|
Marisa L, de Reyniès A, Duval A, Selves J,
Gaub MP, Vescovo L, Etienne-Grimaldi MC, Schiappa R, Guenot D,
Ayadi M, et al: Gene expression classification of colon cancer into
molecular subtypes: Characterization, validation, and prognostic
value. PLoS Med. 10:e10014532013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sinicrope FA, Shi Q, Smyrk TC, Thibodeau
SN, Dienstmann R, Guinney J, Bot BM, Tejpar S, Delorenzi M,
Goldberg RM, et al: Molecular markers identify subtypes of stage
III colon cancer associated with patient outcomes.
Gastroenterology. 148:88–99. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Warschkow R, Sulz MC, Marti L, Tarantino
I, Schmied BM, Cerny T and Güller U: Better survival in right-sided
versus left-sided stage I–III colon cancer patients. BMC Cancer.
16:5542016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Weerink MA, Struys MM, Hannivoort LN,
Barends CR, Absalom AR and Colin P: Clinical pharmacokinetics and
pharmacodynamics of dexmedetomidine. Clin Pharmacokinet.
56:893–913. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Keating GM: Dexmedetomidine: A review of
its use for sedation in the intensive care setting. Drugs.
75:1119–1130. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Grant MJ, Schneider JB, Asaro LA, Dodson
BL, Hall BA, Simone SL, Cowl AS, Munkwitz MM, Wypij D and Curley
MA; Randomized Evaluation of Sedation Titration for Respiratory
Failure Study Investigators, : Dexmedetomidine use in critically
ill children with acute respiratory failure. Pediatr Crit Care Med.
17:1131–1141. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
van de Donk T, Ward S, Langford R and
Dahan A: Pharmacokinetics and pharmacodynamics of sublingual
sufentanil for postoperative pain management. Anaesthesia.
73:231–237. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Willsie SK, Evashenk MA, Hamel LG, Hwang
SS, Chiang YK and Palmer PP: Pharmacokinetic properties of single-
and repeated-dose sufentanil sublingual tablets in healthy
volunteers. Clin Ther. 37:145–155. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Porela-Tiihonen S, Kokki M and Kokki H:
Sufentanil sublingual formulation for the treatment of acute,
moderate to severe postoperative pain in adult patients. Expert Rev
Neurother. 17:101–111. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ohnesorge H, Alpes A, Baron R and
Gierthmühlen J: Influence of intraoperative remifentanil and
sufentanil on sensory perception: A randomized trial. Curr Med Res
Opin. 32:1797–1805. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qin M, Chen K, Liu T and Shen X:
Dexmedetomidine in combination with sufentanil for postoperative
analgesia after partial laryngectomy. BMC Anesthesiol. 17:662017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Benson AB III, Venook AP, Cederquist L,
Chan E, Chen YJ, Cooper HS, Deming D, Engstrom PF, Enzinger PC,
Fichera A, et al: Colon cancer, version 1.2017, NCCN clinical
practice guidelines in oncology. J Natl Compr Canc Netw.
15:370–398. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schweiger MR, Hussong M, Röhr C and
Lehrach H: Genomics and epigenomics of colorectal cancer. Wiley
Interdiscip Rev Syst Biol Med. 5:205–219. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Soler M, Estevez MC, Villar-Vazquez R,
Casal JI and Lechuga LM: Label-free nanoplasmonic sensing of
tumor-associate autoantibodies for early diagnosis of colorectal
cancer. Anal Chim Acta. 930:31–38. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Arnarson Ö, Butt-Tuna S and Syk I:
Postoperative complications following colonic resection for cancer
are associated with impaired long-term survival. Colorectal Dis.
21:805–815. 2019.PubMed/NCBI
|
|
16
|
Li L, Jin J, Min S, Liu D and Liu L:
Compliance with the enhanced recovery after surgery protocol and
prognosis after colorectal cancer surgery: A prospective cohort
study. Oncotarget. 8:53531–53541. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Devcic A, Schmeling WT, Kampine JP and
Warltier DC: Oral dexmedetomidine preserves baroreceptor function
and decreases anesthetic requirements of halothane-anesthetized
dogs. Anesthesiology. 81:419–430. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen J, Fang JI, Lei Z, Zhang Z, Yiheshan
A and Zhang B: Effect of dexmedetomidine on postoperative cellular
immune function in patients with malignant tumor: A meta-analysis.
Chin J Anesthesiol. 4:454–457. 2018.(In Chinese).
|
|
19
|
Feng M, Chen X, Liu T, Zhang C, Wan L and
Yao W: Dexmedetomidine and sufentanil combination versus sufentanil
alone for postoperative intravenous patient-controlled analgesia: A
systematic review and meta-analysis of randomized controlled
trials. BMC Anesthesiol. 19:812019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ma XX, Luo F and Lan R: Effects of
dexmedetomidine combined with sufentanil on P2X7 receptor
expression in peripheral blood mononuclear cells in patients with
burn pain. Acta Microscopica. 28:2019.
|
|
21
|
Dong CS, Zhang J, Lu Q, Sun P, Yu JM, Wu C
and Sun H: Effect of dexmedetomidine combined with sufentanil for
post-thoracotomy intravenous analgesia:a randomized, controlled
clinical study. BMC Anesthesiol. 17:332017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liuboshevskiĭ PA, Artamonova NI and
Ovechkin AM: Haemostasis disturbances as the component of the
surgical stress-response and possibilities of their correction.
Anesteziol Reanimatol. 3:44–48. 2012.(In Russian).
|
|
23
|
Chen Z, Shao D, Mao Z, Shi L, Zheng Y and
Zhang D: Effect of dexmedetomidine on blood coagulation function
following radical gastrectomy. J Clin Anesthesiol. 33:1086–1090.
2017.
|
|
24
|
Sun HZ, Song YL and Wang XY: Effects of
different anesthetic methods on cellular immune and neuroendocrine
functions in patients with hepatocellular carcinoma before and
after surgery. J Clin Lab Anal. 30:1175–1182. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang XH, Bai Q, Lv MM, Fu HG, Dong TL and
Zhou Z: Effect of dexmedetomidine on immune function of patients
undergoing radical mastectomy: a double blind and placebo control
study. Eur Rev Med Pharmacol Sci. 21:1112–1116. 2017.PubMed/NCBI
|
